Gw Henssler & Associates LTD Biogen Inc. Transaction History

Gw Henssler & Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$275.25 - $318.06 $110,100 - $127,224	-400 Reduced 32.63%	826 $235,000
Q1 2023 Apr 26, 2023	BUY	$256.56 - $292.34 $2,565 - $2,923	10 Added 0.82%	1,226 $340,000
Q3 2022 Nov 04, 2022	BUY	$194.69 - $268.46 $35,822 - $49,396	184 Added 17.83%	1,216 $325,000
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $193,541 - $230,156	1,032 New	1,032 $210,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Gw Henssler & Associates LTD with notifications on news.